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Increased O-GlcNAcylation of Drp1 
by amyloid-beta promotes mitochondrial fission 
and dysfunction in neuronal cells
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Abstract 
As a dynamic organelle, mitochondria continuously fuse and divide with adjacent mitochondria. Imbalance in 
mitochondria dynamics leads to their dysfunction, which implicated in neurodegenerative diseases. However, how 
mitochondria alteration and glucose defect contribute to pathogenesis of Alzheimer’s disease (AD) is still largely 
unknown. Dynamin‐related protein 1 (Drp1) is an essential regulator for mitochondria fission. Among various post‑
translational modifications, O‑GlcNAcylation plays a role as a sensor for nutrient and oxidative stress. In this study, we 
identified that Drp1 is regulated by O‑GlcNAcylation in AD models. Treatment of Aβ as well as PugNAc resulted in 
mitochondrial fragmentation in neuronal cells. Moreover, we found that AD mice brain exhibits an upregulated Drp1 
O‑GlcNAcylation. However, depletion of OGT inhibited Drp1 O‑GlcNAcylation in Aβ‑treated cells. In addition, overex‑
pression of O‑GlcNAc defective Drp1 mutant (T585A and T586A) decreased Drp1 O‑GlcNAcylation and Aβ‑induced 
mitochondria fragmentation. Taken together, these finding suggest that Aβ regulates mitochondrial fission by increas‑
ing O‑GlcNAcylation of Drp1.
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Mitochondria are highly dynamic organelles that con-
tinuously undergo fission and fusion with adjacent mito-
chondria. Therefore, disruption of the balance between 
these two processes results in mitochondrial dysfunc-
tion and aberrations in physiological neuronal func-
tions, which are linked with the pathogenesis of vari-
ous neurodegenerative diseases [1]. Dynamin related 
protein 1 (Drp1), a GTPase, is a critical regulator of 
mitochondria and peroxisome fission [2]. Several post-
translational modifications on Drp1 such as phosphoryl-
ation and S-nitrosylation control mitochondrial dynam-
ics by regulating its GTPase activity [3, 4]. O-linked 
β-N-acetylglucosamine (O-GlcNAc) can dynamically 
modify target proteins by O-GlcNAcylation, which 
attaches O-GlcNAc to proteins. O-GlcNAcylation is con-
trolled by two enzymes, O-GlcNActransferase (OGT) 
and N-acetyl-glucosaminidase (OGA) [5]. Mitochon-
drial dysfunction by amyloid-beta1–42 (Aβ) is an early and 
prominent feature of Alzheimer’s disease (AD). A num-
ber of O-GlcNAcylated proteins are associated with the 
pathology of neurodegenerative diseases. Although it was 
reported that cardiac Drp1 is undergoes more O-Glc-
NAcylation in type 2 diabetic mice [6], the link between 
Drp1 O-GlcNAcylation and AD pathology remains 
largely unknown.
To examine the O-GlcNAcylation of Drp1 in AD mod-
els, primary cultured neurons were treated with either 
Aβ or PugNAc, an OGA inhibitor, with consequent 
increase of O-GlcNAcylation. We found that both Aβ 
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and PugNAc treatment induced mitochondrial frag-
mentation in primary cultured neurons, suggesting that 
O-GlcNAcylation influenced mitochondria fragmenta-
tion (Fig. 1a). As WGA-conjugated-agarose beads bind to 
O-GlcNAc-modified proteins [7], we employed a WGA 
antibody-conjugated agarose beads to confirm whether 
Drp1 is target for O-GlcNAcylation in Aβ-treated cells. 
As shown Fig. 1b, c, notably, Aβ treatment strongly pro-
moted O-GlcNAcylation of Drp1 in both SH-SY5Y neu-
roblastoma cells and primary cultured neurons (Fig. 1b, 
c). As mitochondrial fission is increased in AD brain, we 
wondered whether the level of Drp1 O-GlcNAcylation is 
enhanced in the brain tissues of mice AD model (5 × FAD 
transgenic mice) that overexpress human APP and 
PSEN1 transgenes with a total of five AD-linked muta-
tions [8]. Previously, it was reported that O-GlcNAcyla-
tion of nicastrin is elevated in brain of 5 × FAD mice [9]. 
Consistently, we found that Drp1 O-GlcNAcylation and 
nicastrin are  upregulated in 5 × FAD mice brain com-
pared to that of wild type mice brain (Fig. 1d).
To further investigate how Aβ regulates Drp1 O-Glc-
NAcylation, we examined the role of OGT, which 
attach O-GlcNAc to target protein in SH-SY5Y cells. 
As expected, depletion of OGT by RNA interference 
reduced Drp1 O-GlcNAcylation in Aβ-treated cells 
(Fig.  1e). We then confirmed the possibility of an inter-
action between OGT and Drp1. SH-SY5Y cells overex-
pressing GFP-tagged Drp1 and Flag-tagged-OGT were 
prepared. An immunoprecipitation assay showed that 
Drp1 interacts with OGT and that interaction was much 
more enhanced by Aβ exposure compared with that of 
control cells (Fig.  1f ). Previously, Gawlowski et  al. sug-
gested that the residues Thr-585 and Thr-586 on Drp1 are 
putative targets for O-GlcNAc [6]. To confirm the pres-
ence of Drp1 O-GlcNAcylation residue, we generated an 
O-GlcNAc-defective Drp1 mutant (T585A and T586A/
Drp1 TA). SH-SY5Y cells expressing GFP fused wild type 
Drp1 or GFP-fused Drp1 TA were analyzed by immu-
noprecipitation assay. According to the previous results, 
O-GlcNAcylation of Drp1 was did not occur in the Drp1 
TA mutant in Aβ-treated cells (Fig.  1g). To clarify the 
effect of O-GlcNAcylation on Drp1 activity, we moni-
tored mitochondrial morphology in Aβ-treated cells. As 
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Fig. 1 Aβ induces mitochondria fragmentation by promoting Drp1 O‑GlcNAcylation in neuronal cells. a Primary cultured neuron were exposed to 
control (Con), Aβ (10 µM), or PugNAc (100 µM). Mitochondria were stained with mitotracker‑Red. The mean mitochondrial length was determined 
from images of multiple cells obtained by microscopy. The bar graph indicates means ± SEM. *p < 0.01. The scale bar indicates 10 µm. b Drp1 
O‑GlcNAcylation in response to either Aβ (10 µM) or PugNAc (100 µM) in SH‑SY5Y. Cell lysates were immunoprecipitated (IP) with anti‑WGA‑agarose 
antibody and immunoblotted with anti‑Drp1 antibody. c Drp1 O‑GlcNAcylation by Aβ treatment in primary neuron. d Enhanced Drp1 
O‑GlcNAcylation in brain tissue of 5 × FAD. Mice brain lysates from wild‑type and 5 × FAD were assessed by IP using anti‑WGA‑agarose antibody 
and confirmed with anti‑Drp1 and anti‑Nicastrin antibodies. e Depletion of OGT reduced O‑GlcNAcylation of Drp1. SH‑SY5Y cells transfected with 
scrambled siRNA (Sc) or siRNA for OGT were treated with Aβ (10 µM) and the cell lysates were assessed by IP with anti‑WGA‑agarose antibody and 
immunoblotted with anti‑Drp1. f Interaction between Drp1 and OGT. SH‑SY5Y expressing OGT‑flag and GFP‑Drp1 were treated with Aβ (10 µM) 
and then assessed with IP (anti‑GFP antibody) and immunoblotted with anti‑Flag and anti‑GFP antibodies. g O‑GlcNAcylation of mutant Drp1. 
SH‑SY5Y cells expressing empty vector (Vec), GFP‑Drp1 (Drp1), or GFP‑Drp1 T585A/586A mutant (Drp1 TA) were treated with Aβ (10 µM). The cell 
lysates were assessed by IP with anti‑WGA‑agarose antibody and immunoblotted with anti‑GFP‑antibody. h Mitochondrial fragmentation with Drp1 
mutant. SH‑SY5Y cells expressing empty vector (Vec), GFP‑Drp1 (Drp1), or GFP‑Drp1 T585A/586A mutant (Drp1 TA) were treated with Aβ (10 µM). 
Cells with fragmented mitochondria were counted under a microscopy. The bar graph indicates means ± SEM. *p < 0.01
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mitochondrial fragmentation in Aβ-treated cells. How-
ever, overexpression of Drp1 TA mutant did not enhance 
mitochondrial fission in Aβ-treated cells (Fig. 1h). Taken 
together, these results suggest that Thr-585 and Thr-586 
residues on Drp1 are O-GlcNAcylated and contribute to 
mitochondrial fragmentation in Aβ-exposed cells.
Overstimulation of Drp1 results in excessive mito-
chondrial fragmentation and previous studies have 
reported that Drp1 activity is regulated by several 
post-translational modifications, such as phosphoryla-
tion, S-nitrosylation, SUMOylation, ubiquitination, and 
O-GlcNacylation [1, 4]. Among the modifications, we 
highlighted that S-nitrosylation of Drp1 at Cys644 caused 
mitochondrial fragmentation by increasing its activity in 
brain neurons from AD and Huntington’s disease patients 
[3, 10]. In this study, in addition, we suggest that Aβ can 
induce mitochondrial fission and dysfunction by promot-
ing O-GlcNAcylation of Drp1 in AD models. These find-
ings suggest that Aβ enhances Drp1 activity and causes 
excessive mitochondrial fission in various way, leading 
to mitochondrial dysfunction and neuronal death in AD 
progression. O-GlcNAcylation and phosphorylation 
share medication target residues and their interplay is 
highly complex and comprehensive [5]. Therefore, fur-
ther studies on the implication of O-GlcNAcylation and 
phosphorylation on regulation of Drp1 activity will be 
helpful to provide insight on the role of mitochondrial 
dynamics in AD pathogenesis.
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